Price Alert

Avadel Pharmaceuticals (AVDL)

NASDAQ: AVDL · Real-Time Price · USD

15.00

-0.16 (-1.06%)

At close: Oct 16, 2025, 3:59 PM

14.64

-2.40%

After-hours: Oct 16, 2025, 07:12 PM EDT

-1.06% (1D)

Bid	14.25
Market Cap	1.45B
Revenue (ttm)	221.07M
Net Income (ttm)	-2.92M
EPS (ttm)	-0.02
PE Ratio (ttm)	-750
Forward PE	16.71
Analyst	Buy
Dividends	n/a

Ask	15.59
Volume	1,049,791
Avg. Volume (20D)	1,321,312
Open	15.43
Previous Close	15.16
Day's Range	14.67 - 15.43
52-Week Range	6.38 - 16.66
Beta	1.46
Ex-Dividend Date	n/a

About AVDL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol AVDL

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for AVDL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Avadel Pharmaceuticals is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+14.77%

Avadel Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription

5 months ago

+9.61%

Avadel Pharmaceuticals shares are trading higher after the company raised its FY25 sales guidance.

News

2 weeks ago · seekingalpha.com

Avadel: Mispriced Leader In Once-Nightly Sleep Therapies

Avadel Pharmaceuticals is deeply undervalued, with LUMRYZ and Valiloxybate offering $2B+ peak sales potential in sleep disorders. AVDL's once-at-bedtime Oxybate franchise is clinically superior, paten...

1 month ago · seekingalpha.com

Avadel Pharmaceuticals Plc (AVDL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Avadel Pharmaceuticals plc (NASDAQ:AVDL ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT Company Participants Thomas McHugh - Senior VP, Principal Financial & Ac...

1 month ago · zacks.com

Does Avadel (AVDL) Have the Potential to Rally 27.95% as Wall Street Analysts Expect?

The mean of analysts' price targets for Avadel (AVDL) points to a 28% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in...

2 months ago · zacks.com

Wall Street Analysts Predict a 37.25% Upside in Avadel (AVDL): Here's What You Should Know

The consensus price target hints at a 37.3% upside potential for Avadel (AVDL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r...

2 months ago · seekingalpha.com

Avadel Pharmaceuticals plc (AVDL) Q2 2025 Earnings Call Transcript

Avadel Pharmaceuticals plc (NASDAQ:AVDL ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Gregory J. Divis - CEO & Director Susan Rodriguez - Chief Operating Officer Th...